MedPath

Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction

Phase 4
Terminated
Conditions
Vaginal Delivery
Cesarean Section
Interventions
Registration Number
NCT01190163
Lead Sponsor
Ferring Pharmaceuticals
Brief Summary

This is a comparative trial between oxytocin alone and dinoprostone for cervical ripening in unfavorable cervix pregnant women with 38 or more weeks of gestational age.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
170
Inclusion Criteria
  • Singleton pregnancy
  • Gestational age ≥ 38 weeks
  • Fetal cephalic presentation
  • Bishop score < 6
Exclusion Criteria
  • No uterine scar (no previous delivery by caesarean section)
  • No more than 3 previous vaginal births
  • No condition that disallows use of prostaglandins for induction of labor
  • Premature rupture of the membranes
  • Oligohydramnios

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ADinoprostone-
BOxytocin-
Primary Outcome Measures
NameTimeMethod
Vaginal birth delivery within 24 hours and C-section rate24 hours
Secondary Outcome Measures
NameTimeMethod
Treatment failure rate24 hours
Uterine hyperstimulation and/or fetal distress24 hours
Use of additional oxytocin24 hours

Trial Locations

Locations (4)

Hospital Maternidade Leonor Mendes de Barros

🇧🇷

São Paulo, Brazil

Hospital M Boi Mirim

🇧🇷

São Paulo, Brazil

Hospital Municipal Universitário - Faculdade de Medicina do ABC

🇧🇷

São Bernardo, São Paulo, Brazil

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

🇧🇷

Ribeirão Preto, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath